Results show that cognitive decline, combined with factors like smoking, obesity, and chronic health conditions, sharply ...

Newron today announces its financial and operational results for the half year ended June 30, 2024, and provides an update on ...

EQS-News: Newron Pharmaceuticals S.p.A. / Key word (s): Half Year Results Newron presents H1 2024 results and provides business update 19.09.2024 / 07:00 CET/CEST The issuer is solely responsible ...

A D.C. drugmaker has been dealt a major setback in its long-running bid to bring its treatment for a chronic gastrointestinal ...

A new study by a researcher at the University of Haifa, published in the prestigious journal Molecular Psychiatry, part of ...

Sen. JD Vance (R-Ohio), the Republican vice presidential candidate, is backtracking on whether President Trump would veto a ...

"The new findings reveal a much larger quantity of shared genes, and this is a very significant breakthrough in research.” ...

Reishi has a number of different impacts on our bodies, but one of the major ways it works as a medicine is by influencing ...

Recently initiated SERENITY At-Home pivotal Phase 3 trial for agitation associated with bipolar disorders or schizophrenia ...

Pharmac – Te Pātaka Whaioranga is widening access to seven medicines, benefitting an estimated 5,700 people within the first year of funding. The decision includes treatments for schizophrenia, low ...